(Q44399613)

2 December 2017

title

Treatment of HIV-associated pulmonary hypertension with treprostinil (English)

1 reference

2 December 2017

Luis Cea-Calvo

1

1 reference

2 December 2017

Pilar Escribano Subías

2

1 reference

2 December 2017

Rocío Tello de Menesses

3

1 reference

2 December 2017

María Lázaro Salvador

4

1 reference

2 December 2017

Miguel A Gómez Sánchez

5

1 reference

2 December 2017

Juan F Delgado Jiménez

6

1 reference

2 December 2017

Carlos Pindado Rodríguez

7

1 reference

2 December 2017

María J Ruiz Cano

8

1 reference

2 December 2017

Carlos Sáenz de la Calzada

9

1 reference

2 December 2017

language of work or name

Spanish

0 references

publication date

1 April 2003

1 reference

Revista Española de Cardiología

2 December 2017

published in

1 reference

2 December 2017

volume

56

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

421-425

1 reference

AIDS and the lung: update 1995. 2. New developments in the pulmonary diseases affecting HIV infected individuals

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976889-4

7 January 2021

Primary pulmonary hypertension in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976889-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976889-4

7 January 2021

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976889-4

7 January 2021

Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976889-4

7 January 2021

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976889-4

7 January 2021

Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976889-4

7 January 2021

Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976889-4

7 January 2021

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976889-4

7 January 2021

10.1016/S0300-8932(03)76889-4

Identifiers

DOI

1 reference

2 December 2017

1 reference